2026 ICD-10-CM Diagnosis Code T36.8X1SPoisoning by other systemic antibiotics, accidental (unintentional), sequela

ICD-10-CM CodesS00–T88T36-T50T36

ICD-10-CM T36.8X1S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T36.8X1S is a billable ICD-10-CM diagnosis code for poisoning by other systemic antibiotics, accidental (unintentional), sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T36.8X1S
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by other systemic antibiotics, accidental (unintentional), sequela
Short Description
Poisoning by oth systemic antibiotics, accidental, sequela
Parent Code
Poisoning by other systemic antibiotics, accidental (unintentional)

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT36Poisoning by, adverse effect of and underdosing of systemic antibiotics
This CodeT36.8X1SPoisoning by other systemic antibiotics, accidental (unintentional), sequela

Present on Admission (POA)Billing

T36.8X1S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Accidental fluoroquinolone poisoning
  • Accidental fusidic acid overdose
  • Accidental fusidic acid poisoning
  • Accidental nitrofuran derivative overdose
  • Accidental nitrofuran derivative poisoning
  • Accidental quinolone antibacterial overdose
  • Accidental sulfamethoxazole and/or trimethoprim overdose
  • Accidental sulfamethoxazole and/or trimethoprim poisoning
  • Accidental vancomycin overdose
  • Accidental vancomycin poisoning
  • Fluoroquinolone poisoning
  • Fusidic acid overdose
  • Fusidic acid poisoning
  • Nitrofuran derivative overdose
  • Poisoning by nitrofuran derivatives
  • Quinolone antibacterial overdose
  • Sulfamethoxazole and/or trimethoprim overdose
  • Sulfamethoxazole and/or trimethoprim poisoning
  • Vancomycin overdose
  • Vancomycin poisoning

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of systemic antibiotics (T36). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Capreomycin

    cyclic peptide antibiotic similar to viomycin. it is produced by streptomyces capreolus.
  • Ciprofloxacin

    a broad-spectrum antimicrobial carboxyfluoroquinoline.
  • Clindamycin

    an antibacterial agent that is a semisynthetic analog of lincomycin.
  • Colistin

    cyclic polypeptide antibiotic from bacillus colistinus. it is composed of polymyxins e1 and e2 (or colistins a, b, and c) which act as detergents on cell membranes. colistin is less toxic than polymyxin b, but otherwise similar; the methanesulfonate is used orally.
  • Enoxacin

    a broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to nalidixic acid.
  • Enviomycin

    cyclic basic peptide related to viomycin. it is isolated from an induced mutant of streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.
  • Fleroxacin

    a broad-spectrum antimicrobial fluoroquinolone. the drug strongly inhibits the dna-supercoiling activity of dna gyrase.
  • Fosfomycin

    an antibiotic produced by streptomyces fradiae.
  • Fusidic Acid

    an antibiotic isolated from the fermentation broth of fusidium coccineum. (from merck index, 11th ed). it acts by inhibiting translocation during protein synthesis.
  • Lincomycin

    an antibiotic produced by streptomyces lincolnensis var. lincolnensis. it has been used in the treatment of staphylococcal, streptococcal, and bacteroides fragilis infections.
  • Norfloxacin

    a synthetic fluoroquinolone (fluoroquinolones) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. norfloxacin inhibits bacterial dna gyrase.
  • Levofloxacin

    the l-isomer of ofloxacin.
  • Ofloxacin

    a synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial dna gyrase, halting dna replication.
  • Ristocetin

    an antibiotic mixture of two components, a and b, obtained from nocardia lurida (or the same substance produced by any other means). it is no longer used clinically because of its toxicity. it causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.
  • von Willebrand Factor

    a high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor viii/von willebrand factor complex. the von willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. it functions in adhesion of platelets to collagen and hemostatic plug formation. the prolonged bleeding time in von willebrand diseases is due to the deficiency of this factor.
  • Teicoplanin

    lipoglycopeptide antibiotic from actinoplanes teichomyceticus active against gram-positive bacteria. it consists of five major components each with a different fatty acid moiety.
  • Vancomycin

    antibacterial obtained from streptomyces orientalis. it is a glycopeptide related to ristocetin that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
  • Vancomycin Resistance

    nonsusceptibility of bacteria to the action of vancomycin, an inhibitor of cell wall synthesis.
  • Vancomycin-Resistant Enterococci

    strains of the genus enterococcus that are resistant to the antibiotic vancomycin. the enterococci become resistant by acquiring plasmids carrying genes for vancomycin resistance.
  • Vancomycin-Resistant Staphylococcus aureus

    isolates of the staphylococcus aureus that are resistant to the antibiotic vancomycin. the s. aureus becomes resistant by acquiring plasmids carrying genes for vancomycin resistance. vancomycin‐intermediate s. aureus has low-level vancomycin resistance requiring an intermediate concentration of vancomycin between sensitive and resistant isolates. these s. aureus with reduced susceptibility to vancomycin and related glycopeptide antibiotics are often seen in healthcare associated infections.
  • Viomycin

    a strongly basic peptide, antibiotic complex from several strains of streptomyces. it is allergenic and toxic to kidneys and the labyrinth. viomycin is used in tuberculosis as several different salts and in combination with other agents.
  • Streptogramin A

    a specific streptogramin group a antibiotic produced by streptomyces graminofaciens and other bacteria.
  • Virginiamycin

    a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. loidensis, s. mitakaensis, s. pristina-spiralis, s. ostreogriseus, and others. it consists of 2 major components, virginiamycin factor m1 and virginiamycin factor s1. it is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AerosporinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Aerosporin::ENT agentT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Aerosporin::ophthalmic preparationT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Aerosporin::topical NECT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
AlbamycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
AmfomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
AmphomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
BetamicinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
CapreomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
CarbomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
CathomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
CiprofloxacinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
ClindamycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
ColimycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
ColistimethateT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
ColistinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Colistin::sulfate (eye preparation)T36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Co-trimoxazoleT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
EnoxacinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
EnviomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
FleroxacinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
FosfomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
FugillinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
FumadilT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
FumagillinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
FusafungineT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Fusidate (ethanolamine) (sodium)T36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Fusidic acidT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
LincomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
MagnamycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
MycitracinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Mycitracin::ophthalmic preparationT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
NeosporinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Neosporin::ENT agentT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Neosporin::ophthalmic preparationT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Neosporin::topical NECT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
NorfloxacinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
OfloxacinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
PolymyxinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Polymyxin::BT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Polymyxin::B::ENT agentT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Polymyxin::B::ophthalmic preparationT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Polymyxin::B::topical NECT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
Polymyxin::E sulfate (eye preparation)T36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
RistocetinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
SulfomyxinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
TeicoplaninT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
VancomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
ViomycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6
VirginiamycinT36.8X1T36.8X2T36.8X3T36.8X4T36.8X5T36.8X6

Patient EducationClinical

Antibiotics

Antibiotics are medicines that fight bacterial infections in people and animals. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply.

The full article covers:

  • What are antibiotics?
  • What do antibiotics treat?
  • Do antibiotics treat viral infections?
  • What are the side effects of antibiotics?
  • Why is it important to take antibiotics only when they're needed?
  • How do I use antibiotics correctly?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T36.8X1S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.0 Late eff drug poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E929.2 Late eff acc poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code History & ChangesHistory

Replaced This code was replaced in the FY 2026 code set by:

  • T36.AX1S - Poisoning by fluoroquinolone antibiot, accidental, sequela
  • T36.AX1S - Poisoning by fluoroquinolone antibiot, accidental, sequela
FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T36.8X1SOverview

Is T36.8X1S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by other systemic antibiotics, accidental (unintentional), sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T36.8X1S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by other systemic antibiotics, accidental (unintentional) itself has resolved, not the original event.

What MS-DRG does T36.8X1S group to?

When poisoning by other systemic antibiotics, accidental (unintentional), sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Is T36.8X1S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by other systemic antibiotics, accidental (unintentional), sequela on inpatient claims.

What is the ICD-9 equivalent of T36.8X1S?

Under the General Equivalence Mappings, poisoning by other systemic antibiotics, accidental (unintentional), sequela converts to ICD-9-CM 909.0 (late eff drug poisoning) and E929.2 (late eff acc poisoning). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.